Cargando…
The Conceptualization of Value in the Value Proposition of New Health Technologies : Comment on "Providing Value to New Health Technology: The Early Contribution of Entrepreneurs, Investors, and Regulatory Agencies"
Lehoux et al provide a highly valid contribution in conceptualizing value in value propositions for new health technologies and developing an analytic framework that illustrates the interplay between health innovation supply-side logic (the logic of emergence) and demand-side logic (embedding in the...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Kerman University of Medical Sciences
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5819379/ https://www.ncbi.nlm.nih.gov/pubmed/29524943 http://dx.doi.org/10.15171/ijhpm.2017.75 |
_version_ | 1783301198770601984 |
---|---|
author | Buttigieg, Sandra C. van Hoof, Joost |
author_facet | Buttigieg, Sandra C. van Hoof, Joost |
author_sort | Buttigieg, Sandra C. |
collection | PubMed |
description | Lehoux et al provide a highly valid contribution in conceptualizing value in value propositions for new health technologies and developing an analytic framework that illustrates the interplay between health innovation supply-side logic (the logic of emergence) and demand-side logic (embedding in the healthcare system). This commentary brings forth several considerations on this article. First, a detailed stakeholder analysis provides the necessary premonition of potential hurdles in the development, implementation and dissemination of a new technology. This can be achieved by categorizing potential stakeholder groups on the basis of the potential impact of future technology. Secondly, the conceptualization of value in value propositions of new technologies should not only embrace business/economic and clinical values but also ethical, professional and cultural values, as well as factoring in the notion of usability and acceptance of new technology. As a final note, the commentary emphasises the point that technology should facilitate delivery of care without negatively affecting doctor-patient communications, physical examination skills, and development of clinical knowledge. |
format | Online Article Text |
id | pubmed-5819379 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | Kerman University of Medical Sciences |
record_format | MEDLINE/PubMed |
spelling | pubmed-58193792018-02-23 The Conceptualization of Value in the Value Proposition of New Health Technologies : Comment on "Providing Value to New Health Technology: The Early Contribution of Entrepreneurs, Investors, and Regulatory Agencies" Buttigieg, Sandra C. van Hoof, Joost Int J Health Policy Manag Commentary Lehoux et al provide a highly valid contribution in conceptualizing value in value propositions for new health technologies and developing an analytic framework that illustrates the interplay between health innovation supply-side logic (the logic of emergence) and demand-side logic (embedding in the healthcare system). This commentary brings forth several considerations on this article. First, a detailed stakeholder analysis provides the necessary premonition of potential hurdles in the development, implementation and dissemination of a new technology. This can be achieved by categorizing potential stakeholder groups on the basis of the potential impact of future technology. Secondly, the conceptualization of value in value propositions of new technologies should not only embrace business/economic and clinical values but also ethical, professional and cultural values, as well as factoring in the notion of usability and acceptance of new technology. As a final note, the commentary emphasises the point that technology should facilitate delivery of care without negatively affecting doctor-patient communications, physical examination skills, and development of clinical knowledge. Kerman University of Medical Sciences 2017-07-03 /pmc/articles/PMC5819379/ /pubmed/29524943 http://dx.doi.org/10.15171/ijhpm.2017.75 Text en © 2018 The Author(s); Published by Kerman University of Medical Sciences This is an open-access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Commentary Buttigieg, Sandra C. van Hoof, Joost The Conceptualization of Value in the Value Proposition of New Health Technologies : Comment on "Providing Value to New Health Technology: The Early Contribution of Entrepreneurs, Investors, and Regulatory Agencies" |
title | The Conceptualization of Value in the Value Proposition of New Health Technologies : Comment on "Providing Value to New Health Technology: The Early Contribution of Entrepreneurs, Investors, and Regulatory Agencies" |
title_full | The Conceptualization of Value in the Value Proposition of New Health Technologies : Comment on "Providing Value to New Health Technology: The Early Contribution of Entrepreneurs, Investors, and Regulatory Agencies" |
title_fullStr | The Conceptualization of Value in the Value Proposition of New Health Technologies : Comment on "Providing Value to New Health Technology: The Early Contribution of Entrepreneurs, Investors, and Regulatory Agencies" |
title_full_unstemmed | The Conceptualization of Value in the Value Proposition of New Health Technologies : Comment on "Providing Value to New Health Technology: The Early Contribution of Entrepreneurs, Investors, and Regulatory Agencies" |
title_short | The Conceptualization of Value in the Value Proposition of New Health Technologies : Comment on "Providing Value to New Health Technology: The Early Contribution of Entrepreneurs, Investors, and Regulatory Agencies" |
title_sort | conceptualization of value in the value proposition of new health technologies : comment on "providing value to new health technology: the early contribution of entrepreneurs, investors, and regulatory agencies" |
topic | Commentary |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5819379/ https://www.ncbi.nlm.nih.gov/pubmed/29524943 http://dx.doi.org/10.15171/ijhpm.2017.75 |
work_keys_str_mv | AT buttigiegsandrac theconceptualizationofvalueinthevaluepropositionofnewhealthtechnologiescommentonprovidingvaluetonewhealthtechnologytheearlycontributionofentrepreneursinvestorsandregulatoryagencies AT vanhoofjoost theconceptualizationofvalueinthevaluepropositionofnewhealthtechnologiescommentonprovidingvaluetonewhealthtechnologytheearlycontributionofentrepreneursinvestorsandregulatoryagencies AT buttigiegsandrac conceptualizationofvalueinthevaluepropositionofnewhealthtechnologiescommentonprovidingvaluetonewhealthtechnologytheearlycontributionofentrepreneursinvestorsandregulatoryagencies AT vanhoofjoost conceptualizationofvalueinthevaluepropositionofnewhealthtechnologiescommentonprovidingvaluetonewhealthtechnologytheearlycontributionofentrepreneursinvestorsandregulatoryagencies |